Feb 05, 2018 - Losses on Wall Street and falling bond yields weighed on global markets this week.
Feb 03, 2018 - Most obesity drugs haven't been huge successes. But these stocks just might be.
Feb 01, 2018 - Novo Nordisk (NYSE:NVO) Q4 2017 Earnings Conference Call February 01, 2018 07:00 AM ET Executives Lars Fruergaard Jørgensen - CEO Jesper Brandgaard - CFO Mads Krogsgaard Thomsen - CSO Lars Green - EVP
Feb 01, 2018 - While Allergan's (AGN) Q4 sales are likely to be driven by new as well as established products like Botox and international growth, generic competition for some key products will hurt sales.
Feb 01, 2018 - Novo Nordisk's (NVO) top-line growth was backed by growth in new-generation insulin, Victoza, Saxenda, and haemophilia products.
Jan 30, 2018 - Novo Nordisk (NVO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Jan 30, 2018 - Merck's (MRK) new products like Keytruda and Bridion are likely to drive sales in the fourth quarter. However, headwinds remain in the form of genericization of key drugs and increasing competition.
Jan 30, 2018 - Companies In The News are:
Jan 30, 2018 - Sanofi (SNY) to acquire Ablynx for EUR 3.9 billion to expand its late stage pipeline and strengthen rare blood disorder growth platform.
Jan 29, 2018 - With AbbVie (ABBV) surpassing expectations in the fourth quarter, here's a look at a few important takeaways from the company's conference call.